According to the ninth AIFA report, the Comirnaty vaccine accounted for 68% of adverse event reports and 71.2% of doses administered in the campaign so far.
Notes on verification
Verified against AIFA's official press release and original PDF report, with independent corroboration from Italian media outlets.
Sources
- Sorveglianza dei vaccini anti COVID-19: il nono rapporto AIFA (epicentro.iss.it)
- https://www.aifa.gov.it/en/-/nono-rapporto-aifa-sulla-sorveglianza-dei-vaccini-covid-19 (aifa.gov.it)
- https://www.fedaiisf.it/en/nono-rapporto-aifa-sulla-sorveglianza-dei-vaccini-covid-19/ (fedaiisf.it)
- https://www.aifa.gov.it/documents/20142/1315190/Rapporto_sorveglianza_vaccini_COVID-19_9.pdf (aifa.gov.it)
- https://www.startmag.it/sanita/vaccini-reazioni-avverse-decessi-report-aifa/ (startmag.it)